500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
The purpose of the research study is to develop a new, more sensitive, and less invasive
test for diagnosing lung cancer at an earlier stage, when it can more easily be cured. The
investigators hypothesize that certain genes are expressed differently in current and former
smokers who have lung cancer, and this difference in gene expression may be a biomarker for
Active, not recruiting
Ages:21 and older
Inclusion Criteria: - Patients being evaluated for the diagnosis of possible lung cancer or "rule out lung cancer" and undergoing clinically indicated bronchoscopy - All patients are required to be at least 21 years of age and be able to understand and sign the informed consent form - Patient must be a current or former cigarette smoker Exclusion Criteria: - A pulmonary physician does not recommend that bronchoscopy be performed - Inability to understand the written consent form and comply with requirements of the study - History of prior primary lung cancer - Immediately prior to bronchoscopy, the patient has been on a mechanical ventilator for >24 consecutive hours.
Sponsor: Allegro Diagnostics, Corp.
Trial ID: NCT00746759
Not Accepting Healthy Volunteers